Cargando…

Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic

IMPORTANCE: The opioid crisis has been exacerbated by the COVID-19 pandemic in the US, with concerns over major disruptions to medication treatment of opioid use disorder. OBJECTIVE: To investigate whether the COVID-19 pandemic was associated with disruption of buprenorphine and methadone supplies i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Annie Y., Powell, David, Stein, Bradley D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327579/ https://www.ncbi.nlm.nih.gov/pubmed/35881394 http://dx.doi.org/10.1001/jamanetworkopen.2022.23708

Ejemplares similares

Opioid replacement therapy with methadone or buprenorphine effects on male mice reproduction
por: Moinaddini, Fatemeh, et al.
Publicado: (2022)

Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID
por: Meyerson, Beth E., et al.
Publicado: (2022)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

The Effects of Methadone and Buprenorphine on Testis of Rats
por: Corsi, Karen F.
Publicado: (2012)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
por: Tanz, Lauren J., et al.
Publicado: (2023)

Demographic and Geospatial Analysis of Buprenorphine and Methadone Prescription Rates
por: Peterman, Nicholas J, et al.
Publicado: (2022)

29. Use of Buprenorphine for Opioid Use Disorder among US Adolescents and Young Adults During the COVID-19 Pandemic
por: Alinsky, Rachel, et al.
Publicado: (2022)

Racial, Ethnic, and Sex Differences in Methadone-Involved Overdose Deaths Before and After the US Federal Policy Change Expanding Take-home Methadone Doses
por: Harris, Rebecca Arden, et al.
Publicado: (2023)

Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic
por: Alinsky, Rachel H., et al.
Publicado: (2022)

Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes
por: Taylor, Erin A., et al.
Publicado: (2023)

Changes in Cancer Screening in the US During the COVID-19 Pandemic
por: Fedewa, Stacey A., et al.
Publicado: (2022)

'Diversion’ of methadone or buprenorphine: 'harm’ versus 'helping’
por: Havnes, Ingrid Amalia, et al.
Publicado: (2013)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US
por: Han, Beth, et al.
Publicado: (2021)

Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic
por: Nguyen, Thuy, et al.
Publicado: (2022)

Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada
por: Joudrey, Paul J., et al.
Publicado: (2021)

Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
por: Aldabergenov, D, et al.
Publicado: (2022)

Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic
por: Frost, Madeline C., et al.
Publicado: (2022)

P.0615 Biopsychosocial effect of the Covid-19 pandemic in patients under medication-assisted treatment with methadone and buprenorphine
por: Leventelis, C., et al.
Publicado: (2021)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Methadone, Buprenorphine, and Street Drug Interactions with Antiretroviral Medications
por: Gruber, Valerie A., et al.
Publicado: (2010)

Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
por: Hassan, Rahimah, et al.
Publicado: (2021)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes
por: Lund, Ingunn O, et al.
Publicado: (2012)

Buprenorphine, methadone, and morphine treatment during pregnancy: behavioral effects on the offspring in rats
por: Chen, Hwei-Hsien, et al.
Publicado: (2015)

Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US
por: Duncan, Alexandra, et al.
Publicado: (2020)

The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
por: Wapf, Victoria, et al.
Publicado: (2008)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Perioperative Management of Patients on Buprenorphine and Methadone: A Narrative Review
por: Sritapan, Yasmin, et al.
Publicado: (2020)

Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients
por: Delorme, Jessica, et al.
Publicado: (2021)

Clinical Case Conference: Strategies for Transferring From Methadone to Buprenorphine
por: Hill, Duncan, et al.
Publicado: (2022)

Analytical Approaches for the Determination of Buprenorphine, Methadone and Their Metabolites in Biological Matrices
por: Shan, Xiaoyue, et al.
Publicado: (2022)

Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
por: Goshgarian, Gregory, et al.
Publicado: (2022)

Methadone, Buprenorphine, Oxycodone, Fentanyl and Tramadol in Multiple Postmortem Matrices
por: Havig, Stine Marie, et al.
Publicado: (2021)

Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic
por: Cantor, Jonathan, et al.
Publicado: (2021)

Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines
por: Lintzeris, Nicholas, et al.
Publicado: (2018)

Changes in Smoking Cessation–Related Behaviors Among US Adults During the COVID-19 Pandemic
por: Bandi, Priti, et al.
Publicado: (2022)

US dental health care workers’ mental health during the COVID-19 pandemic
por: Eldridge, Laura A., et al.
Publicado: (2022)

Analysis of Firearm Violence During the COVID-19 Pandemic in the US
por: Sun, Shengzhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ov9jjeousk041jnsiq5h1eo6qt